Late-breaking Trials from the 2016 American Heart Association's Scientific Sessions. 

 -  2017 
<br/><br/>Available in print through MWHC library: 2002 - present 
<br/><br/> Copyright © 2016. Published by Elsevier Inc.  The late breaking trials released at the American Heart Association scientific sessions conference in November in New Orleans, LA covered a wide range of topics, including new devices within the field of heart failure, new registry data on transcatheter aortic valve replacement (TAVR) in intermediate risk patients, and medical management of peripheral arterial disease, coronary artery disease, and hypercholesterolemia. The following review highlights the late breaking trials presented at the conference that will have significant impact on clinical practice. 
<br/><br/><br/>English 
<br/><br/><label>ISSN: </label>1878-0938 
<br/><br/><label>Subjects--Topical Terms: </label><br/>*Biomedical Research<br/>*Cardiology<br/>*Cardiovascular Diseases/th [Therapy]<br/>Cardiovascular Diseases/di [Diagnosis]<br/>Cardiovascular Diseases/mo [Mortality]<br/>Cardiovascular Diseases/pp [Physiopathology]<br/>Clinical Trials as Topic<br/>Humans<br/>Treatment Outcome
<br/><br/><label>Subjects--Geographic Terms: </label><br/>MedStar Heart & Vascular Institute
<br/><br/><label>Index Terms--Function: </label><br/>Congresses